静脉未分离肝素完全基于体重的方案与非基于体重的剂量滴定方案的比较:一项前后研究。

IF 0.6 Q4 PHARMACOLOGY & PHARMACY
Thomas Cameron, Doson Chua, Stephen Shalansky, Edwin Tam, Erica Wang
{"title":"静脉未分离肝素完全基于体重的方案与非基于体重的剂量滴定方案的比较:一项前后研究。","authors":"Thomas Cameron,&nbsp;Doson Chua,&nbsp;Stephen Shalansky,&nbsp;Edwin Tam,&nbsp;Erica Wang","doi":"10.4212/cjhp.3265","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Unfractionated heparin (UFH) is used for the prevention and treatment of arterial or venous thromboembolism. The dosage for IV infusion of UFH is generally based on the patient's weight, with adjustment to a specific target for activated partial thromboplastin time (aPTT). In May 2019, the UFH protocols at the study institution were changed from being fully weight-based (i.e., for both initial dosing and subsequent dosage titrations) to weight-based initial dosing and non-weight-based dosage titrations, but the relative effectiveness of these 2 approaches was not known.</p><p><strong>Objectives: </strong>The primary objective was to compare the effectiveness in achieving therapeutic aPTT with the fully weight-based and non-weight-based dosage titration protocols. The secondary objective was to compare the effectiveness of the non-weight-based dosage titration protocol with that of the previous fully weight-based one for patients with low-target aPTT.</p><p><strong>Methods: </strong>A single-centre, retrospective, observational before-and-after study was conducted for patients receiving therapeutic UFH for any indication. Patients in the \"before\" group (fully weight-based protocol) were treated from January 2015 to October 2016, and those in the \"after\" group (non-weight-based titration) from January to October 2020.</p><p><strong>Results: </strong>From a total of 1969 charts screened, 137 patients treated according to the fully weight-based protocols and 130 patients treated according to the non-weight-based titration protocols were included. In terms of the co-primary objective, the median number of dosage adjustments to achieve therapeutic anticoagulation was 1 in both groups (<i>p</i> = 0.48), and the proportion of patients with therapeutic anticoagulation at 24 h was similar (96.2% [125/130] with the non-weight-based titration protocols versus 99.3% [136/137] with the fully weight-based protocols; <i>p</i> = 0.09). Among patients treated according to the low-target UFH protocols, those with the non-weight-based titration protocol were less likely to have therapeutic anticoagulation at first measurement of aPTT than those with the fully weight-based protocol (37.9% [25/66] versus 44.6% [41/92], <i>p</i> = 0.033).</p><p><strong>Conclusions: </strong>This retrospective, observational, before-and-after study showed that the effectiveness of the non-weight-based dosage titration protocols in achieving therapeutic aPTT was similar to that of fully weight-based UFH protocols.</p>","PeriodicalId":51646,"journal":{"name":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","volume":"76 1","pages":"23-28"},"PeriodicalIF":0.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817222/pdf/cjhp-76-23.pdf","citationCount":"0","resultStr":"{\"title\":\"Comparison of a Fully Weight-Based Protocol with a Non-Weight-Based Dosage Titration Protocol for IV Unfractionated Heparin: A Before-and-After Study.\",\"authors\":\"Thomas Cameron,&nbsp;Doson Chua,&nbsp;Stephen Shalansky,&nbsp;Edwin Tam,&nbsp;Erica Wang\",\"doi\":\"10.4212/cjhp.3265\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Unfractionated heparin (UFH) is used for the prevention and treatment of arterial or venous thromboembolism. The dosage for IV infusion of UFH is generally based on the patient's weight, with adjustment to a specific target for activated partial thromboplastin time (aPTT). In May 2019, the UFH protocols at the study institution were changed from being fully weight-based (i.e., for both initial dosing and subsequent dosage titrations) to weight-based initial dosing and non-weight-based dosage titrations, but the relative effectiveness of these 2 approaches was not known.</p><p><strong>Objectives: </strong>The primary objective was to compare the effectiveness in achieving therapeutic aPTT with the fully weight-based and non-weight-based dosage titration protocols. The secondary objective was to compare the effectiveness of the non-weight-based dosage titration protocol with that of the previous fully weight-based one for patients with low-target aPTT.</p><p><strong>Methods: </strong>A single-centre, retrospective, observational before-and-after study was conducted for patients receiving therapeutic UFH for any indication. Patients in the \\\"before\\\" group (fully weight-based protocol) were treated from January 2015 to October 2016, and those in the \\\"after\\\" group (non-weight-based titration) from January to October 2020.</p><p><strong>Results: </strong>From a total of 1969 charts screened, 137 patients treated according to the fully weight-based protocols and 130 patients treated according to the non-weight-based titration protocols were included. In terms of the co-primary objective, the median number of dosage adjustments to achieve therapeutic anticoagulation was 1 in both groups (<i>p</i> = 0.48), and the proportion of patients with therapeutic anticoagulation at 24 h was similar (96.2% [125/130] with the non-weight-based titration protocols versus 99.3% [136/137] with the fully weight-based protocols; <i>p</i> = 0.09). Among patients treated according to the low-target UFH protocols, those with the non-weight-based titration protocol were less likely to have therapeutic anticoagulation at first measurement of aPTT than those with the fully weight-based protocol (37.9% [25/66] versus 44.6% [41/92], <i>p</i> = 0.033).</p><p><strong>Conclusions: </strong>This retrospective, observational, before-and-after study showed that the effectiveness of the non-weight-based dosage titration protocols in achieving therapeutic aPTT was similar to that of fully weight-based UFH protocols.</p>\",\"PeriodicalId\":51646,\"journal\":{\"name\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"volume\":\"76 1\",\"pages\":\"23-28\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817222/pdf/cjhp-76-23.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CANADIAN JOURNAL OF HOSPITAL PHARMACY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4212/cjhp.3265\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.3265","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:未分离肝素(UFH)用于预防和治疗动脉或静脉血栓栓塞。静脉输注UFH的剂量通常基于患者的体重,并调整到激活部分凝血活素时间(aPTT)的特定目标。2019年5月,该研究机构的UFH方案从完全以体重为基础(即初始剂量和后续剂量滴定)改为以体重为基础的初始剂量和非以体重为基础的剂量滴定,但这两种方法的相对有效性尚不清楚。目的:主要目的是比较完全基于体重和非基于体重的剂量滴定方案在实现治疗性aPTT方面的有效性。次要目的是比较非基于体重的剂量滴定方案与先前完全基于体重的剂量滴定方案对低靶点aPTT患者的有效性。方法:对任何适应症接受治疗性UFH的患者进行单中心、回顾性、前后观察性研究。2015年1月至2016年10月为治疗前组(完全基于体重的方案),2020年1月至10月为治疗后组(非基于体重的滴定)。结果:从总共筛选的1969个图表中,137例患者根据完全基于体重的方案治疗,130例患者根据非基于体重的滴定方案治疗。在共同主要目标方面,两组实现治疗性抗凝的剂量调整中位数为1次(p = 0.48), 24小时治疗性抗凝的患者比例相似(非体重滴定方案为96.2%[125/130],而完全体重滴定方案为99.3% [136/137];P = 0.09)。在按照低靶点UFH方案治疗的患者中,与完全基于体重的方案相比,采用非基于体重的滴定方案的患者在首次测量aPTT时进行抗凝治疗的可能性更低(37.9%[25/66]对44.6% [41/92],p = 0.033)。结论:这项回顾性、观察性、前后对照研究表明,非基于体重的剂量滴定方案在实现治疗性aPTT方面的有效性与完全基于体重的UFH方案相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of a Fully Weight-Based Protocol with a Non-Weight-Based Dosage Titration Protocol for IV Unfractionated Heparin: A Before-and-After Study.

Background: Unfractionated heparin (UFH) is used for the prevention and treatment of arterial or venous thromboembolism. The dosage for IV infusion of UFH is generally based on the patient's weight, with adjustment to a specific target for activated partial thromboplastin time (aPTT). In May 2019, the UFH protocols at the study institution were changed from being fully weight-based (i.e., for both initial dosing and subsequent dosage titrations) to weight-based initial dosing and non-weight-based dosage titrations, but the relative effectiveness of these 2 approaches was not known.

Objectives: The primary objective was to compare the effectiveness in achieving therapeutic aPTT with the fully weight-based and non-weight-based dosage titration protocols. The secondary objective was to compare the effectiveness of the non-weight-based dosage titration protocol with that of the previous fully weight-based one for patients with low-target aPTT.

Methods: A single-centre, retrospective, observational before-and-after study was conducted for patients receiving therapeutic UFH for any indication. Patients in the "before" group (fully weight-based protocol) were treated from January 2015 to October 2016, and those in the "after" group (non-weight-based titration) from January to October 2020.

Results: From a total of 1969 charts screened, 137 patients treated according to the fully weight-based protocols and 130 patients treated according to the non-weight-based titration protocols were included. In terms of the co-primary objective, the median number of dosage adjustments to achieve therapeutic anticoagulation was 1 in both groups (p = 0.48), and the proportion of patients with therapeutic anticoagulation at 24 h was similar (96.2% [125/130] with the non-weight-based titration protocols versus 99.3% [136/137] with the fully weight-based protocols; p = 0.09). Among patients treated according to the low-target UFH protocols, those with the non-weight-based titration protocol were less likely to have therapeutic anticoagulation at first measurement of aPTT than those with the fully weight-based protocol (37.9% [25/66] versus 44.6% [41/92], p = 0.033).

Conclusions: This retrospective, observational, before-and-after study showed that the effectiveness of the non-weight-based dosage titration protocols in achieving therapeutic aPTT was similar to that of fully weight-based UFH protocols.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CANADIAN JOURNAL OF HOSPITAL PHARMACY
CANADIAN JOURNAL OF HOSPITAL PHARMACY PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
64
期刊介绍: The CJHP is an academic journal that focuses on how pharmacists in hospitals and other collaborative health care settings optimize safe and effective drug use for patients in Canada and throughout the world. The aim of the CJHP is to be a respected international publication serving as a major venue for dissemination of information related to patient-centred pharmacy practice in hospitals and other collaborative health care settings in Canada and throughout the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信